— Know what they know.
Not Investment Advice

AKUS NASDAQ

Akouos, Inc.
1W: +1.0% 1M: +0.9% 3M: +296.7% 1Y: +72.8%
$13.29
Last traded 2022-11-30 — delisted
NASDAQ · Healthcare · Biotechnology

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$87M -77.3% ▼
Net Income
-$87M -78.3% ▼
EPS (Diluted)
$-4.94 -78.3% ▼
EBITDA
-$83M -69.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021
Revenue$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0
Gross Profit$0$0$0$0
Gross Margin————
R&D Expenses$6M$20M$34M$65M
SG&A Expenses$2M$3M$15M$22M
Operating Expenses$7M$24M$49M$87M
Operating Income-$7M-$24M-$49M-$87M
Operating Margin————
Interest Expense$0$0$0$0
Income Before Tax-$6M-$26M-$49M-$87M
Tax Expense$0$0$0$0
Net Income-$6M-$26M-$49M-$87M
Net Margin————
EPS (Diluted)$-0.93$-4.00$-2.77$-4.94
EBITDA-$6M-$25M-$49M-$83M
Shares Outstanding6M6M18M18M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms